DeepMed Research

UNIVERSITY COLLEGE LONDON

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1826-02-11

Employees: 10K

Market Cap: -

Website: http://www.ucl.ac.uk

Clinical Trials

[18F]FPIA PET/CT Imaging in Patients With Solid Tumours

Phase 2

Recruiting

Conditions: Cancer
Tumor, Solid

Interventions: Drug: [18F]Fluoropivalate ([18F]Fluoro-2,2-Dimethylpropionic Acid)
Procedure: PET/CT

First Posted Date: 2021-01-22

Last Posted Date: 2023-10-03

Lead Sponsor: University College, London

Target Recruit Count: 21

Registration Number: NCT04717674

Locations: 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom
🇬🇧
Guy's & St. Thomas' NHS Foundation Trust, London, United Kingdom
🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom

Different Dialysis Modalities and Diet on Gastrointestinal Biome and Azotaemic Toxins

Recruiting

Conditions: Kidney Failure

First Posted Date: 2021-01-19

Last Posted Date: 2021-01-19

Lead Sponsor: University College, London

Target Recruit Count: 100

Registration Number: NCT04714853

Locations: 🇬🇧
Royal Free Hospital, London, United Kingdom

Group CST Using Zoom: A Proof of Concept Study

Not Applicable

Conditions: Dementia

Interventions: Other: Online Cognitive Stimulation Therapy

First Posted Date: 2021-01-05

Last Posted Date: 2021-01-05

Lead Sponsor: University College, London

Target Recruit Count: 50

Registration Number: NCT04695743

Locations: 🇬🇧
University College London, London, United Kingdom

Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

Phase 3

Recruiting

Conditions: Hodgkin Lymphoma

Interventions: Radiation: Involved site radiotherapy
Drug: Doxorubicin
Drug: Bleomycin
Drug: Brentuximab vedotin
Drug: Vinblastine
Drug: Dacarbazine
Drug: Haematopoietic growth factor

First Posted Date: 2020-12-28

Last Posted Date: 2025-05-07

Lead Sponsor: University College, London

Target Recruit Count: 1042

Registration Number: NCT04685616

Locations: 🇺🇸
Stanford University - (Stanford Cancer Institute), Stanford, California, United States
🇺🇸
University of Miami School of Medicine, Miami, Florida, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 55 locations

CiproPAL (Ciprofloxacin Prophylaxis in Acute Leukaemia)

Not Applicable

Recruiting

Conditions: Acute Lymphoblastic Leukaemia - Category

Interventions: Drug: Ciprofloxacin
Drug: Antibiotic

First Posted Date: 2020-12-22

Last Posted Date: 2024-03-08

Lead Sponsor: University College, London

Target Recruit Count: 1052

Registration Number: NCT04678869

Locations: 🇬🇧
Addenbrookes Hospital, Cambridge, United Kingdom
🇬🇧
Nottingham Children's Hospital, Nottingham, United Kingdom
🇬🇧
Bristol Royal Hospital for Children, Bristol, United Kingdom

and more 11 locations

Transcranial Direct Current Stimulation in Post-stroke Fatigue

Not Applicable

Completed

Conditions: Fatigue
Stroke

Interventions: Device: Anodal tDCS
Device: sham tDCS

First Posted Date: 2020-11-18

Last Posted Date: 2020-11-18

Lead Sponsor: University College, London

Target Recruit Count: 33

Registration Number: NCT04634864

Locations: 🇬🇧
33 Queen Square, Institute of Neurology, UCL, London, United Kingdom

Mechanisms of Excess Risk in Aortic Stenosis

Recruiting

Conditions: Aortic Stenosis
Non-Sustained VT
Heart Failure

Interventions: Diagnostic Test: Cardiac MRI scan
Diagnostic Test: Serum biomarkers (High sensitivity troponin, NT-proBNP
Procedure: Implantable Loop Recorder
Diagnostic Test: 6 minute walk test
Diagnostic Test: Echocardiogram

First Posted Date: 2020-11-13

Last Posted Date: 2021-04-30

Lead Sponsor: University College, London

Target Recruit Count: 192

Registration Number: NCT04627987

Locations: 🇬🇧
Barts Heart Centre, London, United Kingdom

Use of Frequency Compression in Severe-profound Hearing Loss Adults

Not Applicable

Completed

Conditions: Frequency Compression
Severe-profound Hearing Impairment

First Posted Date: 2020-11-10

Last Posted Date: 2020-11-10

Lead Sponsor: University College, London

Target Recruit Count: 27

Registration Number: NCT04623112

Study of Plasma Exchange in Severe COVID-19

Phase 2

Completed

Conditions: COVID19

Interventions: Drug: OCTAPLAS

First Posted Date: 2020-11-10

Last Posted Date: 2024-06-07

Lead Sponsor: University College, London

Target Recruit Count: 23

Registration Number: NCT04623255

Locations: 🇬🇧
University College London Hospital, London, United Kingdom

Lentiviral Gene Therapy for Epilepsy

Phase 1

Not yet recruiting

Conditions: Drug Resistant Epilepsy

Interventions: Genetic: lentiviral gene therapy

First Posted Date: 2020-10-26

Last Posted Date: 2023-05-15

Lead Sponsor: University College, London

Target Recruit Count: 10

Registration Number: NCT04601974

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy